| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 21.3 | 18.7 | 22.0 |
| Other income | 1.0 | 0.3 | 0.5 |
| Total income | 22.3 | 19.1 | 22.5 |
| Profit before exceptional items & tax | 1.9 | 2.8 | 2.1 |
| Profit before tax | 1.9 | 2.8 | 2.1 |
| Net profit | 1.4 | 2.0 | 1.7 |
| Operating margin | 8.5% | 14.7% | 9.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -17.60% |
|---|---|
| Net profit, quarter on quarter | -30.00% |
| Revenue, year on year | -3.20% |
Source
Read the filing ↗
NSE results filing, NSE: GML. Figures extracted from the filing.
Galaxy Medicare Ltd: key numbers
- Share price
- ₹16.95
- Market cap
- ₹25.72 Cr
- Revenue (annual)
- ₹40.00 Cr
- Net profit (annual)
- ₹3.42 Cr
- P/E (TTM)
- 7.5×Sector 57.8×
- Promoter holding
- 72.98%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Galaxy Medicare Ltd
All →
17:32 IST
NSE
Dividend
Galaxy Medicare Dividend
Galaxy Medicare Limited has fixed September 11, 2026, as the record date for determining shareholder entitlement to the final dividend for the 2025-26 financial year.